- Home
- ZEPP vs COEP Comparison
ZEPP vs COEP Comparison
Compare ZEPP & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- COEP
- Stock Information
- Founded
- ZEPP 2013
- COEP 2017
- Country
- ZEPP Netherlands
- COEP United States
- Employees
- ZEPP N/A
- COEP N/A
- Industry
- ZEPP Computer Manufacturing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZEPP Technology
- COEP Health Care
- Exchange
- ZEPP Nasdaq
- COEP Nasdaq
- Market Cap
- ZEPP 37.1M
- COEP 32.0M
- IPO Year
- ZEPP N/A
- COEP N/A
- Fundamental
- Price
- ZEPP $2.36
- COEP $9.30
- Analyst Decision
- ZEPP
- COEP
- Analyst Count
- ZEPP 0
- COEP 0
- Target Price
- ZEPP N/A
- COEP N/A
- AVG Volume (30 Days)
- ZEPP 33.4K
- COEP 29.3K
- Earning Date
- ZEPP 05-19-2025
- COEP 05-14-2025
- Dividend Yield
- ZEPP N/A
- COEP N/A
- EPS Growth
- ZEPP N/A
- COEP N/A
- EPS
- ZEPP N/A
- COEP N/A
- Revenue
- ZEPP $181,183,000.00
- COEP $62,874.00
- Revenue This Year
- ZEPP $758.69
- COEP N/A
- Revenue Next Year
- ZEPP N/A
- COEP N/A
- P/E Ratio
- ZEPP N/A
- COEP N/A
- Revenue Growth
- ZEPP N/A
- COEP N/A
- 52 Week Low
- ZEPP $2.06
- COEP $2.31
- 52 Week High
- ZEPP $4.38
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- ZEPP 39.20
- COEP 48.19
- Support Level
- ZEPP $2.35
- COEP $9.14
- Resistance Level
- ZEPP $2.61
- COEP $9.85
- Average True Range (ATR)
- ZEPP 0.22
- COEP 0.55
- MACD
- ZEPP -0.03
- COEP -0.03
- Stochastic Oscillator
- ZEPP 18.05
- COEP 23.97
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.